Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines.

× No keyword cloud information.

19 in total

1. Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.

Authors: Wei Bu; Gregory M Hayes; Hui Liu; Lorraine Gemmell; David O Schmeling; Pierce Radecki; Fiona Aguilar; Peter D Burbelo; Jennifer Woo; Henry H Balfour; Jeffrey I Cohen
Journal: Clin Vaccine Immunol Date: 2016-04-04

Review 2. Oncogenic properties of human viruses.

Authors: R Glaser; B Decker; F Rapp
Journal: In Vitro Date: 1975 May-Jun

3. Clinically distinguishable syndromes caused by viruses.

Authors: R E Haynes; P H Azimi; H G Cramblett; M D Hilty; D L Burech; K I Koranyi
Journal: Curr Probl Pediatr Date: 1975-04

4. Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid.

Authors: S M Lemon; L M Hutt; J S Pagano
Journal: J Virol Date: 1978-01 Impact factor: 5.103

5. Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis.

Authors: E Kieff; J Levine
Journal: Proc Natl Acad Sci U S A Date: 1974-02 Impact factor: 11.205

6. Epstein-Barr virus infections.

Authors: P J Middleton
Journal: Can Med Assoc J Date: 1974-01-05 Impact factor: 8.262

7. An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.

Authors: Joost Snijder; Michael S Ortego; Connor Weidle; Andrew B Stuart; Matthew D Gray; M Juliana McElrath; Marie Pancera; David Veesler; Andrew T McGuire
Journal: Immunity Date: 2018-04-17 Impact factor: 31.745

8. Epstein-Barr virus. Heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leukocytes.

Authors: T Shope; G Miller
Journal: J Exp Med Date: 1973-01-01 Impact factor: 14.307

9. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors: G R Nemerow; F C Jensen; N R Cooper
Journal: J Clin Invest Date: 1982-11 Impact factor: 14.808

10. Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay.

Authors: Junji Sashihara; Peter D Burbelo; Barbara Savoldo; Theodore C Pierson; Jeffrey I Cohen
Journal: Virology Date: 2009-07-07 Impact factor: 3.616